Merck & Co (MRK) Saham Harga
Merck & Co Harga
Pendapatan tumbuh 5,7% per tahun selama 19 tahun terakhir menjadi 64,93 miliar USD. Laba per saham tumbuh 7,0% per tahun selama 19 tahun terakhir. margin bersih Merck & Co saat ini 28,1%, naik dari 26,8% beberapa tahun lalu. Merck & Co saat ini menawarkan imbal hasil dividen sekitar 2,23%. Rasio pembayaran sekitar 45% dari laba. Dividen tumbuh 4,1% per tahun selama 19 tahun terakhir. Target harga median analis adalah 144,00 USD, di bawah harga saat ini sebesar 2,2%. Dari 36 analis, 26 merekomendasikan beli — konsensus keseluruhan Beli.
Harga saham Merck & Co
Akses data ini lewat Eulerpool API
100.000 permintaan/bulan gratis · tanpa kartu
Model bisnis dan analisis saham Merck & Co
Pertanyaan yang sering diajukan tentang saham Merck & Co
The business model of Merck & Co Inc is centered around the development, manufacturing, and marketing of innovative pharmaceutical products and vaccines. Merck's primary aim is to improve and save lives by addressing unmet medical needs. Through rigorous research and development, the company focuses on discovering novel therapies and delivering them to patients worldwide. Merck operates across various therapeutic areas, including oncology, infectious diseases, vaccines, cardiovascular health, and more. By combining scientific expertise with a strong commitment to patients and healthcare professionals, Merck continually strives to advance medical science and make a positive impact on global health.
Merck & Co Inc is primarily active in the pharmaceutical and healthcare industries.
The main competitors of Merck & Co Inc in the market are Johnson & Johnson, Pfizer Inc, Novartis AG, and Bristol-Myers Squibb Company.
Merck & Co Inc is a renowned pharmaceutical company with a rich history and notable background. Established in 1891, Merck & Co Inc has been dedicated to enhancing global health and improving people's lives. The company has evolved into one of the leading players in the pharmaceutical industry, specializing in research, development, and manufacturing of innovative medications and vaccines. Merck & Co Inc has proactively contributed to medical advancements, from pioneering treatments for diseases like HIV/AIDS to addressing various health challenges. With a commitment to scientific excellence and patient well-being, Merck & Co Inc continues to shape the future of healthcare worldwide.
Merck & Co Inc, a leading pharmaceutical company, has achieved significant milestones throughout its history. The company's notable achievements include the development and launch of groundbreaking drugs like Gardasil, a vaccine for preventing cervical cancer, and Keytruda, an innovative immunotherapy for treating various types of cancer. Merck & Co Inc has also contributed to medical advancements with its research and development efforts, resulting in breakthroughs in areas such as HIV/AIDS treatment and vaccines. The company's commitment to improving global health has resulted in partnerships and initiatives aimed at tackling diseases like malaria and Ebola. Merck & Co Inc continues to make strides in the pharmaceutical industry, focusing on innovative solutions for unmet medical needs.
Merck & Co Inc is primarily present in several countries and regions across the world. The company has a strong global presence, with operations in the United States, Europe, Asia-Pacific, Latin America, and Africa. Merck & Co Inc has established a significant presence in key markets such as the United States, Germany, Japan, China, and Brazil. With its wide international footprint, Merck & Co Inc is committed to delivering its innovative healthcare solutions to patients and healthcare professionals worldwide.
Merck & Co Inc represents a strong commitment to scientific innovation, integrity, and improving global health. As a leading pharmaceutical company, Merck aims to discover, develop, and provide high-quality healthcare solutions. The company's corporate philosophy revolves around putting patients first, valuing diversity and inclusion, and taking responsibility for environmental sustainability. Merck is dedicated to delivering innovative medicines and vaccines, ensuring affordability and access for patients worldwide. With a focus on research, collaboration, and ethical business practices, Merck strives to make a positive impact on society and enhance the well-being of individuals around the globe.
Analis saat ini menetapkan target harga rata-rata 140,42 USD untuk saham Merck & Co (median: 144,00 USD), yaitu -3,3 % terhadap harga terbaru. Konsensus didasarkan pada 36 peringkat analis.
36 analis saat ini menilai saham Merck & Co: 26 merekomendasikan beli, 10 tahan, dan 0 jual. Untuk 2026, analis memperkirakan Merck & Co menghasilkan pendapatan 67,06 miliar USD dan laba per saham 2,68 USD.
Dengan kurs saat ini, saham Merck & Co diperdagangkan pada 131,25 EUR (147,19 USD).
Saham Merck & Co (MRK) tercatat di 11 bursa, termasuk: NYSE (MRK), London (0QAH.L), SIX (Zürich) (MRK1.SW), XETRA (6MK.DE), Frankfurt (6MK.F), München (6MK.MU), Düsseldorf (6MK.DU), Hamburg (6MK.HM).
Merck & Co Inc is one of the leading global pharmaceutical companies focused on the discovery, development, and marketing of drugs, vaccines, and biologics for a variety of diseases and disorders. The company is headquartered in Kenilworth, New Jersey and operates worldwide in over 140 countries.
Pendapatan diperkirakan dari Merck & Co adalah 67,06 miliar USD. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.
Laba diperkirakan dari Merck & Co adalah 6,68 miliar USD. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.
Rasio harga-terhadap-pendapatan (PER) Merck & Co saat ini adalah 54,85. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Merck & Co.
Rasio harga-terhadap-penjualan (PSR) Merck & Co saat ini adalah 5,46. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Merck & Co.
Skor Kualitas AlleAktien untuk Merck & Co adalah 6/10.
ISIN dari Merck & Co adalah US58933Y1055. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.
WKN dari Merck & Co adalah A0YD8Q. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.
Ticker dari Merck & Co adalah MRK. Simbol ticker digunakan untuk memperdagangkan saham Merck & Co di bursa saham.
Saham Merck & Co
Kelompok Peer Merck & Co
Merck & Co Ticker
Merck & Co FIGI
Semua metrik fundamental dan analisis mendalam Merck & Co
Analisis saham kami untuk saham Merck & Co mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Merck & Co. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.